|
1
|
Hutchinson L: Screening: Improved model
for lung cancer detection. Nat Rev Clin Oncol. 10:1832013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Keith RL and Miller YE: Lung cancer
chemoprevention: current status and future prospects. Nat Rev Clin
Oncol. 10:334–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mallakin A, Sugiyama T, Taneja P, et al:
Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
Cancer Cell. 12:381–394. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Damsky WE, Curley DP, Santhanakrishnan M,
et al: β-catenin signaling controls metastasis in Braf-activated
Pten-deficient melanomas. Cancer Cell. 20:741–754. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eijkelenboom A and Burgering BM: FOXOs:
signalling integrators for homeostasis maintenance. Nat Rev Mol
Cell Biol. 14:83–97. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lam EW, Brosens JJ, Gomes AR and Koo CY:
Forkhead box proteins: tuning forks for transcriptional harmony.
Nat Rev Cancer. 13:482–495. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Santo EE, Stroeken P, Sluis PV, Koster J,
Versteeg R and Westerhout EM: FOXO3a is a major target of
inactivation by PI3K/AKT signaling in aggressive neuroblastoma.
Cancer Res. 73:2189–2198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Savkovic SD: Decreased FOXO3 within
advanced human colon cancer: implications of tumour suppressor
function. Br J Cancer. 109:297–298. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hong ZY, Lee HJ, Shin DY, Kim SK, Seo M
and Lee EJ: Inhibition of Akt/FOXO3a signaling by constitutively
active FOXO3a suppresses growth of follicular thyroid cancer cell
lines. Cancer Lett. 314:34–40. 2012. View Article : Google Scholar
|
|
10
|
Salih DA, Rashid AJ, Colas D, et al: FoxO6
regulates memory consolidation and synaptic function. Genes Dev.
26:2780–2801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim DH, Perdomo G, Zhang T, et al: FoxO6
integrates insulin signaling with gluconeogenesis in the liver.
Diabetes. 60:2763–2774. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim DH, Zhang T, Lee S, et al: FoxO6
integrates insulin signaling with MTP for regulating VLDL
production in the liver. Endocrinology. 155:1255–1267. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li M, Chen D, Shiloh A, et al:
Deubiquitination of p53 by HAUSP is an important pathway for p53
stabilization. Nature. 416:648–653. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hopewell EL, Zhao W, Fulp WJ, et al: Lung
tumor NF-κB signaling promotes T cell-mediated immune surveillance.
J Clin Invest. 123:2509–2522. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang G, Li J, Purkayastha S, et al:
Hypothalamic programming of systemic ageing involving IKK-β, NF-κB
and GnRH. Nature. 497:211–216. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saha A, Kuzuhara T, Echigo N, Fujii A,
Suganuma M and Fujiki H: Apoptosis of human lung cancer cells by
curcumin mediated through up-regulation of “growth arrest and DNA
damage inducible genes 45 and 153”. Biol Pharm Bull. 33:1291–1299.
2010. View Article : Google Scholar
|
|
17
|
Dar A, Shibata E and Dutta A:
Deubiquitination of Tip60 by USP7 determines the activity of the
p53-dependent apoptotic pathway. Mol Cell Biol. 33:3309–3320. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Rozieres S, Maya R, Oren M and Lozano
G: The loss of mdm2 induces p53-mediated apoptosis. Oncogene.
19:1691–1697. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sui G, Affar el B, Shi Y, et al: Yin Yang
1 is a negative regulator of p53. Cell. 117:859–872. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holowaty MN, Zeghouf M, Wu H, et al:
Protein profiling with Epstein-Barr nuclear antigen-1 reveals an
interaction with the herpesvirus-associated ubiquitin-specific
protease HAUSP/USP7. J Biol Chem. 278:29987–29994. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li M, Brooks CL, Kon N and Gu W: A dynamic
role of HAUSP in the p53-Mdm2 pathway. Mol Cell. 13:879–886. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang S, Jensen JP, Ludwig RL, Vousden KH
and Weissman AM: Mdm2 is a RING finger-dependent ubiquitin protein
ligase for itself and p53. J Biol Chem. 275:8945–8951. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iwakuma T and Lozano G: MDM2, an
introduction. Mol Cancer Res. 1:993–1000. 2003.
|
|
24
|
Jung CH, Kim J, Park JK, et al: Mdm2
increases cellular invasiveness by binding to and stabilizing the
Slug mRNA. Cancer Lett. 335:270–277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qinyu L, Long C, Zhen-dong D, et al: FOXO6
promotes gastric cancer cell tumorigenicity via upregulation of
C-myc. FEBS Lett. 587:2105–2111. 2013. View Article : Google Scholar : PubMed/NCBI
|
